mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.

Saved in:
Bibliographic Details
Title: mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.
Authors: Girard B; Moderna, Inc., Cambridge, MA, United States., Figueroa AL; Moderna, Inc., Cambridge, MA, United States., De Rosa SC; Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, Seattle, WA, United States., McElrath MJ; Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, Seattle, WA, United States., Azzi JR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Stolman D; Moderna, Inc., Cambridge, MA, United States., Siangphoe U; Moderna, Inc., Cambridge, MA, United States., de Windt E; Moderna, Inc., Cambridge, MA, United States., Miller JM; Moderna, Inc., Cambridge, MA, United States., Das R; Moderna, Inc., Cambridge, MA, United States., Priddy F; Moderna, Inc., Cambridge, MA, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Apr 03; Vol. 16, pp. 1505871. Date of Electronic Publication: 2025 Apr 03 (Print Publication: 2025).
Publication Type: Clinical Trial, Phase III; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1505871